Stay updated on Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The study has expanded to include 34 locations, and the website has been updated to version v2.10.0, replacing the previous version v2.9.7.
    Difference
    0.3%
    Check dated 2024-07-23T14:34:31.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T08:03:33.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the web page.
    Difference
    0.1%
    Check dated 2024-07-02T13:13:45.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of 'Follicular Lymphoma Lymphosarcoma' has been updated to 'Lymphosarcoma Follicular Lymphoma' in the web page, reflecting a revision from v2.9.3 to v2.9.5.
    Difference
    0.3%
    Check dated 2024-06-27T09:39:09.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 'Lymphosarcoma Follicular Lymphoma Revision: v2.9.1' to 'Follicular Lymphoma Lymphosarcoma Revision: v2.9.3'. This change represents an update in the revision version from v2.9.1 to v2.9.3 for the mentioned conditions.
    Difference
    0.3%
    Check dated 2024-06-26T08:35:40.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The value 'Show more Revision: v2.9.0' has been updated to 'MedlinePlus related topics: Lymphoma Genetic and Rare Diseases Information Center resources: Lymphosarcoma Follicular Lymphoma Drug Information available for: Idelalisib Loncastuximab tesirine FDA Drug and Device Resources'. This change represents an update in the information related to the study, including additional resources and drug information.
    Difference
    35%
    Check dated 2024-06-25T08:08:25.000Z thumbnail image

Stay in the know with updates to Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial page.